Viewing Study NCT04837508


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-06-17 @ 7:35 PM
Study NCT ID: NCT04837508
Status: UNKNOWN
Last Update Posted: 2021-12-10
First Post: 2021-04-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Sponsor: Shanghai Miracogen Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced or Metastatic Biliary Tract Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MRG002 View
None Antibody Drug Conjugate (ADC) View
None HER2 View
None Biliary Tract Cancer View